American Shared Hospital Services (AMS)

Price$1.45

Value ScoreA

Growth ScoreC

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-45.40%

Price vs S&P 500 (4W)-19.09%

VGM Score55.07

Market Capitalization$9.61M

P/E Ratio (Annual)4.08x

All Metrics

P/CF (Annual)3.10x

Book Value / Share (Quarterly)$3.56

P/TBV (Annual)0.58x

Revenue Growth (3Y)12.45%

Cash Flow / Share (Quarterly)$-0.14

Price vs S&P 500 (YTD)-41.74%

Gross Margin (TTM)18.62%

Net Profit Margin (TTM)-5.30%

EPS (TTM)$-0.23

10-Day Avg Trading Volume0.09M

EPS Excl Extra (TTM)$-0.23

Revenue Growth (5Y)9.50%

EPS (Annual)$-0.23

ROI (Annual)-3.76%

Gross Margin (Annual)18.03%

Net Profit Margin (5Y Avg)2.57%

Cash / Share (Quarterly)$0.75

Revenue Growth QoQ (YoY)15.90%

EPS Growth (5Y)23.99%

P/E Normalized (Annual)4.08x

ROA (Last FY)-2.80%

Revenue Growth TTM (YoY)-0.62%

EBITD / Share (TTM)$0.35

ROE (5Y Avg)2.41%

Operating Margin (TTM)-11.06%

Cash Flow / Share (Annual)$-0.69

P/B Ratio0.41x

P/B Ratio (Quarterly)0.41x

Net Income / Employee (Annual)$-18,900

EV / Revenue (TTM)0.74x

Net Interest Coverage (TTM)0.99x

ROA (TTM)-2.64%

EV / EBITDA (TTM)9.15x

EPS Incl Extra (Annual)$-0.23

Current Ratio (Annual)0.76x

Quick Ratio (Quarterly)0.74x

3-Month Avg Trading Volume0.12M

52-Week Price Return-39.42%

EV / Free Cash Flow (Annual)3.36x

Revenue / Employee (TTM)$354,300

Tangible BV / Share (Quarterly)$3.55

P/S Ratio (Annual)0.34x

Asset Turnover (Annual)0.51x

52-Week High$3.11

Operating Margin (5Y Avg)1.93%

EPS Excl Extra (Annual)$-0.23

CapEx CAGR (5Y)75.39%

Tangible BV CAGR (5Y)4.54%

26-Week Price Return-29.47%

Quick Ratio (Annual)0.72x

13-Week Price Return-31.78%

Total Debt / Equity (Annual)0.72x

Current Ratio (Quarterly)0.77x

Enterprise Value$21.48M

Revenue / Share Growth (5Y)8.02%

Asset Turnover (TTM)0.50x

Book Value / Share Growth (5Y)1.89%

Revenue / Employee (Annual)$342,500

Inventory Turnover (Annual)350.53x

Pretax Margin (Annual)-11.47%

Cash / Share (Annual)$0.53

3-Month Return Std Dev91.35%

Gross Margin (5Y Avg)34.97%

Net Income / Employee (TTM)$-18,800

EBITDA CAGR (5Y)-3.35%

EBITDA Interim CAGR (5Y)-22.46%

ROE (Last FY)-6.46%

Net Interest Coverage (Annual)5.94x

EPS Basic Excl Extra (Annual)$-0.23

P/FCF (TTM)2.84x

Receivables Turnover (TTM)3.01x

Total Debt / Equity (Quarterly)0.72x

EPS Incl Extra (TTM)$-0.23

Receivables Turnover (Annual)2.54x

ROI (TTM)-3.52%

P/S Ratio (TTM)0.33x

Pretax Margin (5Y Avg)2.86%

Revenue / Share (Annual)$4.24

Tangible BV / Share (Annual)$3.64

Forward P/E46.67x

Price vs S&P 500 (52W)-67.63%

Year-to-Date Return-30.81%

5-Day Price Return8.15%

EPS Normalized (Annual)$-0.23

ROA (5Y Avg)1.11%

Net Profit Margin (Annual)-5.53%

Month-to-Date Return0.69%

Cash Flow / Share (TTM)$0.85

EBITD / Share (Annual)$0.32

EPS Growth (3Y)118.18%

Operating Margin (Annual)-12.78%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)3.50x

ROI (5Y Avg)1.40%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.23

P/TBV (Quarterly)0.41x

P/B Ratio (Annual)0.57x

Inventory Turnover (TTM)779.20x

Pretax Margin (TTM)-9.83%

Book Value / Share (Annual)$3.66

Price vs S&P 500 (13W)-41.52%

Net Margin Growth (5Y)19.23%

Beta0.33x

P/FCF (Annual)1.40x

Revenue / Share (TTM)$4.32

ROE (TTM)-6.38%

52-Week Low$1.25

vGradeA

gGradeC

mGradeD

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-0.09est. -0.01

Analyst Recommendations

Sep 2021

Oct 2021

Nov 2021

Dec 2021

4.00

Industry Peers — Health Services(28)

Symbol	Value Score	Growth Score	Momentum Score	Price
AMSAmerican Shared Hospital Services	A	C	D	$1.45
NTRANatera, Inc. Common Stock	F	A	B	$218.81
DGXQuest Diagnostics Inc.	C	D	C	$192.20
LHLabcorp Holdings Inc.	C	D	C	$256.87
EXASExact Sciences Corp	F	B	B	$0.00
GHGuardant Health, Inc. Common Stock	F	A	A	$129.14
CELCCelcuity Inc. Common Stock	—	—	B	$122.96
CAICaris Life Sciences, Inc. Common Stock	F	F	C	$16.45
RDNTRadNet, Inc. Common Stock	D	C	D	$52.89
VCYTVeracyte, Inc.	D	A	B	$48.18
GRALGRAIL, Inc. Common Stock	D	A	B	$64.40

About

American Shared Hospital Services supplies specialized radiation therapy equipment, including Gamma Knife stereotactic radiosurgery systems and advanced radiation therapy devices, to hospitals and standalone medical facilities. The company operates three main business segments: Gamma Knife systems, advanced radiation therapy equipment and services, and proton beam radiation therapy operations. Revenue is primarily generated from the domestic U.S. market.